NCT05767684 2023-08-25Neoantigen Derived DCs as Cancer TreatmentNational Health Research Institutes, TaiwanPhase 1 Unknown12 enrolled
NCT04699071 2021-10-21Trial of Lenvatinib Plus PembrolizumAb in Recurrent Gynecological Clear Cell Adenocarcinomas (LARA)National University Hospital, SingaporePhase 2 Unknown10 enrolled